학술논문

Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial
Document Type
Article
Source
In The Lancet Haematology February 2022 9(2):e121-e132
Subject
Primary Research
Articles
Language
ISSN
2352-3026